Published in Clin Exp Allergy on September 01, 2006
Eosinophil survival and apoptosis in health and disease. Allergy Asthma Immunol Res (2010) 0.97
Activation states of blood eosinophils in asthma. Clin Exp Allergy (2014) 0.90
Applications of snake venom components to modulate integrin activities in cell-matrix interactions. Int J Biochem Cell Biol (2013) 0.84
An imbalance in C/EBPs and increased mitochondrial activity in asthmatic airway smooth muscle cells: novel targets in asthma therapy? Br J Pharmacol (2009) 0.80
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost (2005) 3.47
Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation (2001) 1.61
Blood coagulation at the site of microvascular injury: effects of low-dose aspirin. Blood (2001) 1.54
Humoral immunosuppression in men exposed to polycyclic aromatic hydrocarbons and related carcinogens in polluted environments. Environ Health Perspect (1994) 1.49
More on: Fluvastatin inhibits upregulation of tissue factor expression by antiphospholipid antibodies on endothelial cells. J Thromb Haemost (2005) 1.46
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost (2009) 1.28
Structural requirements of echistatin for the recognition of alpha(v)beta(3) and alpha(5)beta(1) integrins. J Biol Chem (1999) 1.27
Viper venom disintegrins and related molecules. Proc Soc Exp Biol Med (1998) 1.21
Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance. Am J Respir Crit Care Med (1995) 1.05
Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation (2001) 1.00
Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of alpha IIb beta 3 and alpha v beta 3 integrins. FEBS Lett (1996) 0.99
The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review. J Clin Psychiatry (1995) 0.96
Hereditary hemorrhagic telangiectasia, factor V Leiden and antiphospholipid syndrome: a case report. Blood Coagul Fibrinolysis (2002) 0.94
The potential role of statins in contrast nephropathy. Clin Nephrol (2004) 0.93
Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. J Rheumatol (1997) 0.90
Immune biomarkers in relation to exposure to particulate matter: a cross-sectional survey in 17 cities of Central Europe. Inhal Toxicol (2000) 0.90
Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation. Lancet (1999) 0.89
Disintegrin interaction with alpha V beta 3 integrin on human umbilical vein endothelial cells: expression of ligand-induced binding site on beta 3 subunit. Exp Cell Res (1996) 0.88
The disintegrin eristostatin interferes with integrin alpha 4 beta 1 function and with experimental metastasis of human melanoma cells. Exp Cell Res (1998) 0.88
Extracellular matrix molecules regulate endothelial cell migration stimulated by lysophosphatidic acid. J Thromb Haemost (2004) 0.88
Disulphide-bond pattern and molecular modelling of the dimeric disintegrin EMF-10, a potent and selective integrin alpha5beta1 antagonist from Eristocophis macmahoni venom. Biochem J (2000) 0.87
Tirofiban provides "platelet anesthesia" during cardiopulmonary bypass in baboons. J Thorac Cardiovasc Surg (1997) 0.85
Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure. J Lab Clin Med (1980) 0.85
Interaction of leukocytes with platelet microparticles derived from outdated platelet concentrates. Thromb Haemost (1998) 0.85
A time-motion study of the activities of attending physicians in an internal medicine and internal medicine-pediatrics resident continuity clinic. Acad Med (2000) 0.84
Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation. J Lab Clin Med (1985) 0.83
A baboon model for hematologic studies of cardiopulmonary bypass. J Lab Clin Med (1997) 0.83
Integrins in pulmonary inflammatory diseases. Curr Pharm Des (2005) 0.83
Antithrombotic actions of statins. Med Sci Monit (2001) 0.82
Avidity of anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Lupus (2012) 0.81
Central nervous system involvement as a major manifestation of rheumatoid arthritis. Rheumatol Int (2007) 0.81
Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome. J Thromb Haemost (2010) 0.81
Regional differences in integrin expression: role of alpha(5)beta(1) in regulating smooth muscle cell functions. Circ Res (2001) 0.81
Fibrinogen receptors in platelet adhesion to surfaces of extracorporeal circuit. Am J Physiol (1987) 0.81
Loss of platelet alpha 2-adrenergic receptors during simulated extracorporeal circulation: prevention with prostaglandin E1. J Lab Clin Med (1985) 0.81
In vivo release and turnover of secreted platelet antiheparin proteins in rhesus monkey (Macaca mulatta). Blood (1980) 0.80
Heart involvement detected by magnetic resonance in a patient with Churg-Strauss syndrome, mimicking severe asthma exacerbation. Allergy (2009) 0.79
Extracellular signal-regulated kinase (ERK) activation is required for GP Ibalpha-dependent endothelial cell migration. Thromb Haemost (2001) 0.79
Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia. Arterioscler Thromb Vasc Biol (1996) 0.79
An international multicentre-laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti-beta2-glycoprotein autoantibodies. J Thromb Haemost (2011) 0.78
Selective recognition of alpha2beta1 integrin by jararhagin, a Metalloproteinase/disintegrin from bBothrops jararaca venom. Thromb Res (2001) 0.78
Factor XIII Val34Leu polymorphism and gamma-chain cross-linking at the site of microvascular injury in healthy and coumadin-treated subjects. J Thromb Haemost (2005) 0.78
Collagen receptors α(1)β(1) and α(2)β(1) integrins are involved in transmigration of peripheral blood eosinophils, but not mononuclear cells through human microvascular endothelial cells monolayer. J Physiol Pharmacol (2012) 0.78
EC3, a heterodimeric disintegrin from Echis carinatus, inhibits human and murine alpha4 integrin and attenuates lymphocyte infiltration of Langerhans islets in pancreas and salivary glands in nonobese diabetic mice. Biochem Biophys Res Commun (2000) 0.78
Successful coronary stent implantation in a patient with primary antiphospholipid syndrome. Blood Coagul Fibrinolysis (1998) 0.78
Integrins involved in the adhesion of megakaryocytes to fibronectin and fibrinogen. Blood (1998) 0.78
Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I. Immunol Res (2015) 0.77
[Allergic reactions to gypsum]. Pol Tyg Lek (1975) 0.77
Effects of prostanoids on generation of superoxide ions by human neutrophils. Prog Clin Biol Res (1987) 0.77
Lupus anticoagulant: performance of the tests as recommended by the latest ISTH guidelines. J Thromb Haemost (2011) 0.77
Summary of the 9th meeting of the European Forum on Antiphospholipid Antibodies. Lupus (2014) 0.76
Association of heart structure and function abnormalities with laboratory findings in patients with systemic lupus erythematosus. Lupus (2011) 0.76
Lung involvement in Churg–Strauss syndrome as related to the activity of the disease. Allergy (2010) 0.76
Serum cobalt-activated acylase and gamma-glutamyl transpeptidase activities in toxic hepatitis. Gut (1975) 0.75
More on: the debate on antiphospholipid syndrome classification criteria. J Thromb Haemost (2009) 0.75
Valvular heart disease in systemic lupus erythematosus: another symptom of the disease or a hallmark of secondary antiphospholipid syndrome? Eur Heart J (1997) 0.75
The effect of phosphorylation of the EF-2 isolated from rat liver cells on protein biosynthesis in vitro. Acta Biochim Pol (1991) 0.75
The substances of plant origin that inhibit protein biosynthesis. Acta Pol Pharm (1998) 0.75
Elongation factors from the Guerin epithelioma and rat liver cells. Acta Biochim Pol (1993) 0.75
[Eosinophils: their structure, function and clinical evaluation]. Postepy Hig Med Dosw (1976) 0.75
[Hypertension and other factors of coronary heart disease risk (author's transl)]. Przegl Lek (1975) 0.75
[In memory of Stefan Niewiarowski (1926-2001)]. Pol Arch Med Wewn (2001) 0.75
[Primary familial cardiomyopathy]. Kardiol Pol (1976) 0.75
Erratum to: Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I. Immunol Res (2015) 0.75
Prostacyclin and the fibrinolytic system in ischemic vascular disease. Thromb Res (1983) 0.75
Dyspnea is related to family functioning in adult asthmatics. J Asthma (2009) 0.75
Arachidonate versus ADP-induced platelet aggregation in acute myocardial infarction. Thromb Haemost (1979) 0.75
Role of kidney in the catabolic clearance of human platelet antiheparin proteins from rat circulation. Blood (1981) 0.75
Observer variation in lower limb venography. J Can Assoc Radiol (1981) 0.75
[Changeability of respiratory tract and skin symptoms in patients with asthma-prurigo syndrome under the influence of emotional and environmental factors]. Przegl Lek (1998) 0.75
Measurement of platelet microparticles during cardiopulmonary bypass by means of captured ELISA for GPIIb/IIIa. Thromb Haemost (1998) 0.75
[Some clinical symptoms and allergens on asthma-prurigo syndrome]. Przegl Lek (1998) 0.75
[Gastric acid secretion and serum pepsinogen levels in patients with asthma in the course of chronic corticosteroid therapy]. Pol Tyg Lek (1976) 0.75
Organics. J Water Pollut Control Fed (1975) 0.75
Quantitation of platelet preservation with prostanoids during simulated bypass. J Surg Res (1987) 0.75
Evaluation of surface-bound heparin and platelet inhibition in a centrifugal pump left ventricular assist system. World J Surg (1985) 0.75
Autoimmune vasculitis and aortic stenosis in aspirin-induced asthma (AIA). Allergy (1997) 0.75
[Cobalt activated acylase in serum of patients poisoned with mushrooms]. Pol Tyg Lek (1976) 0.75
Bleeding time and PAF-acether-induced platelet aggregation in atopy. Agents Actions Suppl (1987) 0.75